]i) were monitored, using the fluorescent probe Zinquin, in human lymphoma cells exposed to the DNA-damaging agent VP-16. Two-photon excitation microscopy showed that Zinquin-Zn 2ϩ forms complexes in cytoplasmic vesicles. [Zn 2ϩ ]i increased in both p53
wt (wild type) and p53 mut (mutant) cells after exposure to low drug doses. In p53 mut cells noncompetent for DNA damage-induced apoptosis, elevated [Zn 2ϩ ]i was maintained at higher drug doses, unlike competent p53 wt cells that showed a collapse of the transient before apoptosis. In p53 wt cells, the [Zn 2ϩ ]i rise paralleled an increase in p53 and bax-to-bcl-2 ratio but preceded an increase in p21 WAF1 , active cell cycle arrest in G2, or nuclear fragmentation. Reducing [Zn 2ϩ ]i, using N,N,NЈ,NЈ-tetrakis(2-pyridylmethyl)ethylenediamine, caused rapid apoptosis in both p53 wt and p53 mut cells, although cotreatment with VP-16 exacerbated apoptosis only in p53 wt cells. This may reflect changed thresholds for proapoptotic caspase-3 activation in competent cells. We conclude that the DNA damage-induced transient is p53-independent up to a damage threshold, beyond which competent cells reduce [Zn 2ϩ ]i before apoptosis. Early stress responses in p53 wt cells take place in an environment of enhanced Zn 2ϩ availability. flow cytometry; two-photon laser scanning microscopy; zinc THE TRANSITION METAL ZINC is a physiologically important divalent cation in biological systems (43) . The availability of Zn 2ϩ can affect various macromolecular processes, including DNA synthesis, microtubule polymerization, apoptosis, and gene expression (5, 10) . The role of Zn 2ϩ in protein structure and function (12, 13 ) is highlighted by the frequent participation of zinc-sulfur cluster-containing proteins in replication, recombination, and transcription, with the zinc finger structural domain being an important DNA-binding motif. In most cells the free intracellular concentrations of Zn 2ϩ ([Zn 2ϩ ] i ) are extremely low, with the majority being bound to proteins (25, 30, 36) at various subcellular locations (20) . Such locations provide potentially labile stores of Zn 2ϩ for mobilization. Metallothioneins (MTs) are the major intracellular Zn 2ϩ -binding proteins, and changes in their expression will impact on free Zn 2ϩ levels and, consequently, cation availability for cellular processes. For example, the ability of downregulation of MT to induce growth arrest and apoptosis in human breast carcinoma cells (1) may be effected through changes in Zn 2ϩ pools. MT expression can change in response to DNA damage in vivo (3, 22) and appears to be integrated into the stress responses of cells (6, 14) . Thus there is a rationale for expecting shifts in free Zn 2ϩ levels to occur in cells undergoing DNA damage-induced stress responses including caspase activation and the triggering of apoptosis (10, 18) . The control of apoptosis is an essential process in the development and homeostasis of all metazoans. One level of control is through the inhibitor-of-apoptosis proteins (IAPs) that suppress cell death by inhibiting the activity of caspases; this inhibition is performed by Zn 2ϩ -binding domains of IAPs (48) . A recent study (17) has indicated that stress response genes p53, gadd45, and c-fos as well as caspase-3 activity appeared to be modulated by cellular Zn 2ϩ status. Growing normal human bronchial epithelial cells in Zn 2ϩ -deficient medium resulted in elevation of p53 mRNA, nuclear p53 protein, and gadd45 mRNA, and caspase-3 activity was marginally reduced (17) . The active and acute depletion of intracellular Zn 2ϩ , using the chelator N,N,NЈ,NЈ-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN), can induce protein synthesis-dependent neuronal apoptosis in mouse cortical cell cultures (29) or cell death in neuro-2A cells (33) and promotes the formation of internucleosomal DNA fragments in peripheral blood lymphocytes damaged by hydrogen peroxide (44) . TPEN has also been found to induce apoptosis in mouse neuroblastoma cells, and this process could be prevented by equimolar exogenous Zn 2ϩ (35) . Such observations suggest that reductions of intracellular free Zn 2ϩ alone can result in both cellular stress and the triggering of apoptosis and may act in concert with DNA damage to enhance DNA fragmentation. Here we have sought to understand the sequence of any DNA damage-induced shifts in free Zn 2ϩ in cell lines with the differential ability to mount a p53 stress response and, consequently, the differential capacity to engage the apoptotic pathway. Our aim was to reveal the free Zn 2ϩ environment that exists during the mounting of p53-driven stress responses and how this may change in cells undergoing suprathreshold levels of DNA damage and progression to apoptosis.
The tumor suppressor TP53 gene plays a central role in the cellular response to DNA damage. TP53 is the most frequently mutated gene in human cancer and encodes a Zn 2ϩ -requiring transcription factor that can control the traverse of the cell cycle and the commitment to apoptosis of cells exposed to DNA-damaging agents (38) . In cells with functional p53-dependent pathways, DNA damage triggers both G 1 and G 2 arrest of cells (15, 31) . Dysfunction of p53-dependent pathways can allow tumor cells to evade cell cycle checkpoint controls and apoptosis (32) . Cells lacking p53 or its downstream effector, p21 WAF1 , fail to maintain a G 2 arrest following gamma irradiation (8, 47) . The complex tertiary structure of p53 incorporates a Zn 2ϩ -stabilized DNA-binding domain, and mutations affecting this domain of the protein appear to be associated with significantly shorter cancer-related survival for colorectal cancer disease (7) . It is possible that changes in cellular Zn 2ϩ levels can modulate p53 function. Attempts to manipulate protein conformation and function by the removal of Zn 2ϩ have revealed the generation of modified conformational forms of p53 with decreased DNA-binding activity (45) , whereas protein refolding results in increased DNA binding, expression of the downstream effector p21 WAF1 , and cell cycle delay (45) . Thus metalloregulation, comprising intracellular Zn 2ϩ fluxes, could affect p53-dependent driven responses including cell cycle delay and cell death (10) .
The continuous noninvasive tracking of free Zn 2ϩ in single cells, over the time courses required to identify the initiation of cell cycle arrest and cell death, is problematic and not currently possible. Here we have opted to identify DNA damage-induced changes in the low levels of free Zn 2ϩ in individual cells and to correlate these events, using flow cytometry, with the stress responses of p53 stabilization, cell cycle arrest, and apoptosis. The probe Zinquin [(2-methyl-8-p-toluenesulfonamido-6-quinolyloxy)acetic acid] has been used to detect free Zn 2ϩ in intact cells (50, 51) . Intact cells, treated with Zinquin ester (Zinquin E), can be loaded with the probe through intracellular esterase conversion. Zinquin can be used, in a manner analogous to that of the nonratiometric probes for free Ca 2ϩ , to detect free or loosely bound (labile) intracellular Zn 2ϩ by one-photon (4) or two-photon excitation (37) and fluorescence analysis. In the current study we have used continuous exposure to the DNA-damaging topoisomerase II inhibitor VP-16 (etoposide) to induce cycle delay and cell death in lymphoma cells. Under such exposure conditions (39, 41) , VP-16 progressively induces DNA damage through the trapping of topoisomerase II enzyme molecules on DNA in a form that leads to strand break formation and the progressive generation of stress signals for arrest in G 2 and for the triggering of cell death. The results reveal early increases in the low levels of free Zn 2ϩ in cells undergoing DNA damage induction irrespective of p53 function, whereas a reduction in free Zn 2ϩ occurs in cells engaging apoptosis. The results show differences between the engagement of apoptosis through Zn 2ϩ chelation and DNA damage but indicate that the two inducers can cooperate in the promotion of cell death.
MATERIALS AND METHODS

Cell Lines and Culture Conditions
Two human follicular B lymphoma cell lines were used in this study. DoHH2 cells were a kind gift from Dr. J. C. Kluin-Nelemans (Leiden, The Netherlands) (21) , and SU-DHL-4 cells were provided by Dr. F. E. Cotter (16) . DoHH2 was routinely maintained in RPMI 1640 supplemented with 5% FCS. SU-DHL-4 cells were cultured in RPMI 1640 supplemented with 10% FCS (Autogen Bioclear). HL-60 cells (ATCC CCL-240; acute promyelocytic leukemia) were included in this study as an immunoblotting control for p21 WAF1/SDI1/CIP1 and were grown in RPMI 1640 supplemented with 20% FCS. All growth media were supplemented with 100 U/ml penicillin, 100 g/ml streptomycin, and 2 mM glutamine. The cell lines were passaged twice weekly at an initiating density of 5 ϫ 10 4 cells/ml cultured at 37°C in a humid atmosphere of 5% CO2-95% air. The p53 status of the DoHH2 (wild type) and SU-DHL-4 (mutant) cell lines was confirmed by immunocytochemistry, immunoblotting, and analysis of exons 5-8 SSCP (P. J. Smith, unpublished data).
Reagents
Zinquin E {[2-methyl-8-(4-methylphenylsulfonylamino)-quinolinyl]oxyacetic acid ethyl ester} was purchased from Alexis and stored as a 5 mM stock solution in ethanol at 4°C. VP-16 (VP-16-213; VEPESID) was provided as a 34 mM stock solution (Bristol Meyers Pharmaceuticals, Syracuse, NY) and stored at 4°C. Fluorescein-conjugated annexin V (annexin V-FITC) was purchased from Pharmingen (Becton Dickinson UK, Oxford, UK.). Propidium iodide (PI) was obtained as a 1 mg/ml solution in H 2O (Molecular Probes Europe, Leiden, The Netherlands).
Flow Cytometric Analysis of p53 Content
Approximately 1-5 ϫ 10 6 cells were pelleted by centrifugation at 1,250 g for 10 min at 4°C. The cell pellet was loosened by gentle tapping and then incubated for 15 min on ice with 0.25% paraformaldehyde (PFA) made up in PBS. The cells were pelleted and washed once with PBS. The cell pellet was washed once with PBS and fixed with 5 ml of 70% ethanol at Ϫ20°C for 2 h or overnight. The fixed cells were pelleted by centrifugation and rehydrated by being washed in PBS. The cells were permeabilized with 0.25% Triton X-100 in PBS for 5 min on ice and rinsed with PBS. The cells were then incubated with 100 l of primary antibody [Pab-6 (clone DO-1), anti-human pantropic p53 mouse IgG 2a antibody; Oncogene Sciences] diluted 1:100 in antibody dilution buffer (PBS, 5% nonfat milk, and 0.1% Triton X-100) for 1 h at room temperature or overnight at 4°C. The cells were rinsed with PBS and incubated with FITC-conjugated secondary antibody diluted in antibody dilution buffer for 1 h at room temperature. Cells were rinsed with PBS and resuspended with 1 ml of 5 g/ml PI in PBS and 0.1% RNase A.
Immunoblotting
Approximately 2 ϫ 10 6 cells were pelleted by centrifugation at 1,250 g for 5 min, washed once with ice-cold PBS, and lysed with 100 l of sample loading buffer (34) . Cell lysates were boiled for 5 min to denature proteins and were transferred immediately onto ice. Cellular debris and DNA material were removed by centrifugation, and lysates were electrophoresed on 12% SDS-polyacrylamide gels (24) . Proteins were electrophoretically transferred to nitrocellulose membranes (Immobilon-P; Millipore) in transfer buffer (25 mM Tris, pH 8.3, 192 mM glycine, and 20% methanol) (42) , and gels were stained to check for equal loading. Membranes were incubated in 5% skim milk made up in wash buffer (100 mM Tris, pH 7.5, 0.9% wt/vol NaCl, and 0.1% Tween 20) at room temperature for 1 h to minimize nonspecific binding of antibody before washing and antibody incubation. Antibodies used were diluted in wash buffer and comprised anti-human p21 WAF1/SDI1/CIP1 (clone 6B6, mouse IgG1; Pharmingen) used at 1:50 dilution, anti-human bcl-2 (mouse IgG; kindly supplied by Dr. F. E. Cotter) used at 1:50 dilution, and antihuman bax (rabbit IgG; Santa Cruz) used at 1:50. The membranes were washed and incubated with appropriate dilutions (1:2,000-1:5,000) of horseradish peroxidase-linked secondary antibody (Amersham) at room temperature for 1 h. Immune complexes were detected by enhanced chemiluminescence detection (ECL kit; Amersham Biosciences, Amersham, UK).
Analysis of Cell Cycle Changes and Apoptosis
Cell cycle analysis and laser light scatter. Cell cycle analysis as Triton-X-permeabilized and ethidium bromidestained nuclei was performed as described previously (40) . The analysis of laser side/90°light scatter was used to identify nuclear fragments and abnormal nuclear structure.
In situ terminal deoxynucleotidyl transferase assay. Approximately 1 ϫ 10 7 cells/ml (untreated or treated with drugs) were pelleted by centrifugation at 1,250 g for 10 min at 4°C. The pellets were washed once with PBS and fixed in suspension with 5 ml of 4% PFA in PBS at room temperature with gentle agitation for 15 min. The fixed cells were rinsed with PBS, and pellets were resuspended with PBS to obtain 1 ϫ 10 7 cells/ml. Cell suspension (10 ml) was aliquoted onto each well on 15-well poly-lysine-treated slides and incubated for 6-18 h in a humidified chamber to allow cell attachment. Slides were washed in PBS followed by H 2O and then air dried. The cells in each well were incubated with 10 l of direct reaction mixture [78 l dH2O, 20 l of 5ϫ terminal deoxynucleotidyl transferase (TdT) buffer, 1 l of TdT enzyme, and 1 l of fluorescein 11-dUTP (Fluorogreen)] for 1 h at 37°C in a humidified chamber. Slides were rinsed with PBS and H 2O. Cells were counterstained with PI (0.04 g/ml in PBS) for 2 min at room temperature, rinsed, and mounted with VectorShield. Samples were examined by using a BioRad MRC-600 confocal laser scanning microscope operating in dual-channel fluorescence mode for the simultaneous imaging of PI vs. TdT positivity. Cells that had intensely stained nuclear bodies (PI; red) with positive TdT staining (green) were counted (n Ͼ 100) as apoptotic cells containing single-strand DNA breaks, whereas normal cells were those with diffuse nuclear staining and negative staining for TdT.
Annexin V binding. Samples were prepared (46) for the detection of annexin V-FITC surface binding to cells undergoing apoptotic changes and costained with PI to detect loss of plasma membrane integrity.
Loading Conditions for Zn 2ϩ and Zinquin
Cells were grown in asynchronous culture to ϳ6 ϫ 10 5 cells/ml, resuspended in loading buffer [Hanks' balanced salt solution lacking Ca 2ϩ and Mg 2ϩ supplemented with 20 mM HEPES (pH 7.4)], and held at 37°C. Cells were then exposed to 0-100 M Zn 2ϩ with or without sodium pyrithione (1 M) and incubated for 30 min at 37°C. After Zn 2ϩ or control loadings, cells were washed twice rapidly in loading buffer (centrifugation for 30 s at 6,500 rpm with a MicroCentaur microfuge) and resuspended at 6 ϫ 10 5 cells/ml. Suspensions were sham treated or exposed to 25 M Zinquin E and incubated for 30 min at 37°C, and 1 g/ml PI was present for the final 10-min period of incubation. Cell suspensions were analyzed directly by flow cytometry or mounted on microscope slides for imaging.
Analysis of Zinquin-Zn 2ϩ in Single Cells
Flow cytometry. After experimental manipulations were performed, cells were analyzed immediately by using a fluorescence-activated cell sorting Vantage flow cytometer (Becton Dickinson Immunocytometry Systems, San Jose, CA) incorporating an Innova Enterprise II argon ion laser (Coherent, Santa Clara, CA) emitting 488-nm and multiline ultraviolet (MLUV; 351-355 nm, 30 mW) wavelengths. Forward scatter (FSC; master signal) and side scatter (SSC) were acquired in linear mode for 10,000 cells. PI (cell integrity probe) and ethidium bromide (DNA stain for cell cycle analysis) were excited at 488 nm, and fluorescence signals were detected with a 585/42-nm band-pass filter. Zinquin fluorescence (350-to 360-nm excitation wavelength range, 485-nm emission wavelength maximum) originating from the MLUV laser excitation was collected in linear mode at a photomultiplier position protected by DF 424/44-nm and 510-nm dichroic filters. CELLQuest software (Becton Dickinson Immunocytometry Systems) was used for signal acquisition and analysis. Data are expressed as mean fluorescence intensity for populations of single cells. CELLQuest software was used to generate the Kolmogorov-Smirnov statistical analyses for two-sample tests for histograms. The K-S analysis tests whether two selected histograms are different. The calculation computes the summation of the curves and finds the greatest difference between the curves, and then, assuming that the two selected histograms are from the same population, the analysis tests the probability of that difference (D) being as large as measured (49) .
Two-photon excitation laser scanning microscopy. Cells were treated and loaded with Zinquin E. These preparations were placed onto Labtek chambered cover glass (NUNC catalog no. 178565) and mounted onto an inverted microscope (Zeiss Axiovert 100). Three-dimensional (3-D) (x, y, z) images were acquired through the cells by using a laser scanning microscope with two-photon excitation (Bio-Rad 1024MP; Bio-Rad Microscience, Hemel Hempstead, UK). Two-photon excitation (by which infrared light can be used to elicit fluorescence from a UV-excitable fluorochrome) was achieved by using a mode-locked 10-fs pulsed Titanium-Sapphire laser (Verdi-Mira 900; Coherent Lasers, Cambridge, UK) tuned to 780 nm, and fluorescence emission was acquired between 460 and 650 nm. All experiments were conducted with the use of a ϫ60, 1.4-NA, oil-immersion objective lens. For visualization, the entire 3-D image was projected, with the use of a maximum intensity algorithm, into a single two-dimensional view by using standard analysis software (LaserSharp v3.0; Bio-Rad Microscience). Figure 1 , A-D, shows typical results for the measurement of apoptosis induction and progression to cell death in DoHH2 cell populations exposed to VP-16, Zinquin E, or TPEN. The lower right quadrants in Fig.  1 , A-D, delineate cells with high annexin V binding but with intact plasma membranes, defining apoptosis without loss of cellular integrity. After a short period of exposure (Յ4 h) to either Zinquin E or VP-16, cell populations produced profiles the same as those for control cultures with a low background of preexisting apoptotic cells. Figure 1E shows that continued exposure (Ͼ4 h) to VP-16 resulted in a progression of DoHH2 cells to apoptosis (lower right quadrant characteristics) followed by loss of membrane integrity (upper right quadrant characteristics). This finding contrasts with the marked resistance of the SU-DHL-4 cells to VP-16-induced apoptosis (Fig. 1F) . Treatment of DoHH2 cells for 4 h with TPEN resulted in a clear increase in apoptotic fraction (Fig. 1B , lower right quadrant) that retained plasma membrane integrity (no increase in upper right quadrant), suggesting a rapid commitment to cell death upon Zn 2ϩ chelation.
RESULTS
Apoptosis Induced by DNA Damage or Zn 2ϩ chelation
DNA Damage-Induced Cell Cycle Arrest
p53-independent accumulation in G 2 provides a means of evaluating the DNA damage-associated stress responses of the two cell lines. The VP-16 dose dependency (Fig. 2, A and B) and kinetics (Fig. 2, C and D) of cell cycle arrest in the two lymphoma cell lines were determined by analyzing all cells with normal range DNA content. In general the two cell lines showed similar patterns of response, in keeping with their similar cell cycle times, upon long-term (24 h) exposure to 0.125-2 M VP-16, with DoHH2 cells (Fig.  2A) displaying a reduced extent of cell cycle redistribution compared with SU-DHL-4 cells (Fig. 2B) . SU-DHL-4 cells showed a dose-dependent increase in G 2 /M arrest peaking at 0.5 M, at which point G 1 emptying is complete. At doses Ͼ0.5 M VP-16, an increasing number of cells also became trapped in S phase. These data indicate the lack of any significant G 1 /S arrest in SU-DHL-4 cells. The accumulation of DoHH2 cells in G 2 /M was up to threefold less than that for SU-DHL-4 cells at 0.5 M VP-16 with evidence of the retention of cells in G 1 .
Following the kinetics of arrest at the 0.5 M VP-16 level (Fig. 2 , C and D) revealed similar patterns of arrest/delay, with redistribution outside the normal range becoming apparent at Ն4 h of drug exposure. The kinetics also revealed that the two cell lines show similar rates of exit from G 1 , despite initial differences Taken together, these data reveal that exposure to 0.5 M VP-16 is a critical threshold below which the initial cell cycle changes are comparable in the two cell lines, whereas beyond that level of additional stress factors, such as apoptotic engagement in DoHH2, affect distribution patterns. The data provide a VP-16-induced stress profile that permits a rational search for linked changes in free [Zn 2ϩ ] i .
Early Changes in Cell Cycle/Apoptosis Regulators in DoHH2 Cells During VP-16 Treatment
To determine whether VP-16 treatments could differentially engage apoptosis to the level of DNA fragmentation/DNA strand break generation, we examined the frequency of cells showing DNA fragmentation after 24 h of drug exposure. Figure 3A demonstrates that the majority of DoHH2 cells treated with Ն0.25 M VP-16 are destined to become apoptotic. The SU-DHL-4 cell line showed resistance to fragmentation. To link any changes in the expression of p53 in DoHH2 cells with the engagement of the DNA fragmentation process, we used differential stabilization of nuclear bodies by ethanol alone, in which nuclear integrity is fragile, compared with a cross-linking procedure in which nuclear integrity is better preserved by pretreatment with PFA (see MATERIALS AND METHODS). Figure 3B shows the low levels of p53 detected in control DoHH2 cells. VP-16-treated and PFA-prefixed cells showed high levels of p53 induction in all phases, but particularly in the G 2 /M arrested population. Without PFA prefixing, the high p53 expression events were lost to a sub-G 1 fraction (Fig. 3B, arrow) , indicating that their nuclear bodies have undergone disruption. Thus, even at 12 h of drug treatment, there is clear evidence that p53 expression has not been induced in all cells and that these cells preserve nuclear integrity and would contribute to the progressive arrest shown in Fig. 2C . Figure 3C shows that the time course of p53 changes for PFA-prefixed DoHH2 cells. Many cells (Ͼ50% population), in all phases of the cell cycle, showed an early (4 h) increase in p53 levels (beyond the control levels shown by the bold bar and defined in Fig. 3B) , with the remainder showing p53 levels within the range of the untreated control. This elevation of p53 was maintained in cells as they progressed through to G 2 /M arrest, with the cells remaining in G 1 and S phase showing progressive loss of an elevated p53-specific signal. The presence of apoptotic internucleosomal DNA cleavage was confirmed by gel electrophoresis (data not shown). Parallel studies using pulsed-field electrophoresis to detect the initial high-molecularweight fragmentation of DNA indicated that cleavage is not detectable for 0.5 M VP-16-treated DoHH2 cells before 3 h of drug exposure (S.-F. Chin and P. J. Smith, unpublished data). Figure 3D shows the parallel analysis of changes in p21 WAF1 , bcl-2, and bax levels upon drug exposure as indicators of cellular stress responses (23) . The results indicate the early activation of p21
WAF1 by 3 h of drug exposure and its greater expression during cycle arrest with an apparent progressive increase in the bax-tobcl-2 ratio evident after 2 h of drug exposure.
Thus the VP-16 response study identifies treatment conditions under which cycle arrest will ensue in both cell lines with similar kinetics while apoptosis can be differentially engaged. The continuous presence of the DNA-damaging agent VP-16 appears to sustain the elevations in p53 and p21
WAF1 that precede the cell cycle perturbations in DoHH2. p53 (wild type)-depen- dent changes in gene expression were not observed in SU-DHL-4 cells. The flow cytometric analysis demonstrated that DoHH2 cells that become arrested in G 2 /M do so with a sustained increase in p53 and commitment to apoptotic DNA fragmentation.
Subcellular Location of Free Intracellular Zn 2ϩ
Revealed by the Zinquin E Probe
To enable interpretation of the flow cytometric studies of total cellular fluorescence, we used two-photon microscopy (37) to detect the subcellular location and intensity of intracellular Zinquin fluorescence. We examined cells expressing basal levels of free intracellular Zn 2ϩ and cells preloaded with extracellular Zn 2ϩ [i.e., using the ionophore sodium pyrithione as described previously (50)]. Two-photon excitation laser scanning microscopy of Zinquin complexes within these B-cell lymphomas revealed that fluorescence was enhanced by extracellular Zn 2ϩ and was punctate, being localized into a subcellular compartment excluded from the nucleus. Figure 4 , a-e, shows the distribution of ZinquinZn 2ϩ complexes in SU-DHL-4 cells and the effects of ionophore loading with Zn 2ϩ . The images indicate that the basal level of fluorescence associated with Zinquin E incubation is very low compared with that achieved through sodium pyrithione-mediated preloading with Zn 2ϩ , although the punctate patterns appear to be similar. Preincubation of cells with Zn 2ϩ without ionophore suggests that cells can accumulate and sequester Zn 2ϩ in stores accessible to Zinquin. Colocalization studies using the novel cell-permeant DNA dye DRAQ5 (37) indicated that the properties of Zinquin preclude its ability to locate or remain within the nuclear compartment or that ionophore loading of Zn 2ϩ results in metal cation sequestration within nonnuclear vesicles (images not shown). We also observed that mitotic cells lacking a nuclear membrane and cells with clearly defined apoptotic nuclear morphologies also show punctate fluorescence of Zinquin-Zn 2ϩ complexes (images not shown).
Subpopulation Analysis of Early Changes in [Zn 2ϩ ] i During VP-16 Exposure
Because our aim was to detect shifts in free [Zn 2ϩ ] i in these complex cell populations responding to a cytotoxic agent, it was clearly important to exclude dead and/or dying cells from the analyses. Imaging indicated that although such cells esterase-convert Zinquin E, their compromised membrane integrity could result in the reporting of anomalous free [Zn 2ϩ ] i (data not shown). Thus viability was defined in terms of membrane integrity and was determined by PI exclusion (see Fig. 1, A and C) . Preliminary experiments (data not shown) confirmed that flow cytometry could detect the extent of ionophore-mediated loading of extracellular Zn 2ϩ and established standard conditions for Zinquin E loading.
To investigate DNA damage-induced changes in [Zn 2ϩ ] i , our strategy was to investigate the early shifts in Zinquin fluorescence for VP-16 exposures capable of initiating early molecular events (i.e., Ͻ4 h) that precede cycle arrest or have the potential to fully engage apoptosis. With the use of short drug incubation periods, reactive changes in [Zn 2ϩ ] i could be analyzed without the complication of longer term cell cycle redistribution. This analysis period also corresponds to the period during which an enforced fall in free [Zn 2ϩ ] i can induce apoptosis in DoHH2 cells (Fig. 1B) and during which VP-16 can induce significant changes in cell cycle/apoptosis regulators (Fig. 3, C and D) without the immediate expression of apoptotic changes per se (Fig. 1E) . In all experiments in which control cells were treated with Zinquin E alone, with cellular fluorescence reflecting basal levels of free [Zn 2ϩ ] i , we observed a subpopulation of PI-negative cells with high levels of Zinquin fluorescence (Fig. 5A) . The dot plot also shows that the normal background of PI-positive dead DoHH2 cells shows increased Zinquin fluorescence. The increasing Zinquin fluorescence positivity in R2 is not associated with an increase in PI signal despite the assay sensitivity (note the logarithmic scale). It is important to note that the Zinquin and PI signals are generated through excitation at spatially separated laser beams, and therefore the high- (Fig. 6, A and B ] i was set at the median channel for a Zinquin E-treated control, to avoid prejudice in region setting, with shifts shown relative to the control set at zero. The results show that a shift to the high- [Zn 2ϩ ] i fraction was always detected for both cell lines at the lowest VP-16 dose (0.25 M ϫ 3 h) and was significant at 2.5 M VP-16 (P Ͻ 0.05, t-test) for conditions under which apoptosis was not detectable. This increase in PI-negative/high-[Zn 2ϩ ] i cells was reproducible but was always lost as the VP-16 dose was increased in DoHH2 cells, but not in SU-DHL-4 cells. This loss was due to a movement of cells into the low-[Zn 2ϩ ] i fraction rather than loss to the nonviable fraction (PI positive). Hence, the analysis presented in Fig. 6, A and B, reflects a demonstrable "switch" from low to high free [Zn 2ϩ ] i during DNA damage and a subsequent loss of cells from the high fraction reflecting low [Zn 2ϩ ] i . This approach inherently underestimates event frequency because it is not cumulative with time.
The second approach involved the analysis of whole population shifts in [Zn 2ϩ ] i by using Kolmogorov-Smirnov statistics, measuring the significance of the maximum vertical displacement between two cumulative frequency distributions (49) . Figure 7 , A-H, demonstrates the heterogeneity in basal levels of free [Zn 2ϩ ] i and provides evidence of the significance and extent of changes with respect to control distributions. These changes range from an increase in all cells (Fig. 7,  E-H) , a whole population collapse (Fig. 7, C and D) , and a heterogeneous response (Fig. 7, A and B) . Figure  7 , E-H, shows typical whole population shifts for SU-DHL-4 cells, reporting an increased level of free [Zn 2ϩ ] i at all doses of VP-16. DoHH2 cells (Fig. 7, A-D tion, due to the addition of the DNA-damaging agent, is asynchronous with each cell responding at different times and to a different extent. Thus some cells could be increasing free [Zn 2ϩ ] i while others will have already experienced a collapsed transient, giving rise to mixed populations (Fig. 7, A and B) . Furthermore, the inherent heterogeneity in basal free [Zn 2ϩ ] i means that the true amplitude of the rise and the extent of the collapse for a given cell is unknown.
p53-Independent Induction of Apoptosis by TPEN
The results suggested that early apoptotic engagement may be accompanied by or require a fall in [Zn 2ϩ ] i and that Zn 2ϩ chelation by TPEN may be capable of providing an apoptotic trigger in DoHH2 cells (Fig.  1B) . To test whether apoptosis could be induced by TPEN in p53 mutant cells, apoptotic/cell death changes were quantified by the analysis of nuclear changes detected by laser light scatter (40) . Figure 8 , A and B, shows the results of a prolonged (18 h) TPEN exposure to permit the development of apoptotic bodies. The data are presented as 1) normal scatter events (i.e., G 1 to G 2 content DNA with 90°light scatter values within the normal distribution), 2) abnormal scatter events (i.e., G 1 to G 2 content DNA with 90°light scatter values greater than the normal distribution), and 3) fragmentation events (i.e., Ն0.5ϫ G 1 to Ͻ1ϫ G 1 DNA content). Figure 8A shows that Ͼ80% DoHH2 cells show apoptotic characteristics after exposure to Ͼ5 M TPEN. Characteristically, the majority of these cells retained their nuclear DNA content and did not fully fragment even at 250 M TPEN. Figure 8B shows that SU-DHL-4 cells had a more resistant response with Ͼ40% not showing nuclear changes even at the highest dose. However, at Ն5 M TPEN, ϳ20% of the SU-DHL-4 cells underwent nuclear changes consistent with apoptosis and a threefold greater level of fragmentation events compared with DoHH2 cells. The data indicate that TPEN exposure (5-50 M) can induce apoptotic changes in both cell lines. To confirm these observations, we used a complementary method of apoptosis detection, namely, annexin V binding/PI exclusion. The commitment to TPEN-induced apoptosis was found to be rapid and showed similar kinetics for the two cell lines (Fig. 8, C and D) . Commitment was followed, after a delay of ϳ12 h, by essentially the same rate of progression to a nonviable state.
Enhancement of DNA Damage-Induced Apoptosis by Zn 2ϩ Chelation
The data are consistent with an induction of apoptosis through a fall in intracellular Zn 2ϩ availability and indicate that functional pathways for DNA damageinduced apoptosis are not required. The question arises as to whether Zn 2ϩ chelation-facilitated nuclear fragmentation and DNA damage-induced signals for cell death can interact. If so, cells that are permissive for DNA damage-induced apoptosis should be triggered into apoptosis more readily if there is an imposed reduction in free [Zn 2ϩ ] i . This question was tested by using TPEN and the probe Zinquin E itself, because the Zinquin E-cleaved molecules form intracellular complexes with Zn 2ϩ and, hence, act to buffer Zn 2ϩ ions. Figure 9 , A and B, shows results for a selected short exposure to VP-16 that did not generate apoptosis or the loss of membrane integ- C and D) . A and B: ‚, normal scatter events (i.e., G1 to G2 content DNA with 90°light scatter values within the normal distribution); s, abnormal scatter events (i.e., G1 to G2 content DNA with 90°light scatter values greater than the normal distribution); E, fragmentation events (i.e., Ն0.5 G1 to ϽG1 DNA content). C and D: time-dependent changes in the frequency of apoptotic (‚) and nonviable (OE) cells as defined in Fig. 1 ] i transient is expressed in an increasing number of cells as the VP-16 dose, and therefore the probability of recruitment into apoptosis, increases.
Enforcing a fall in free [Zn 2ϩ ] i by using the chelator TPEN in the p53 wild-type cell line, permissive for the engagement of apoptosis in the presence of DNA damage signals, caused a rapid commitment to apoptosis. This suggests that a reduction in free [Zn 2ϩ ] i can act as an apoptotic trigger as observed by others (9, 29, 33, 35, 44) . Our results also indicate that VP-16 cotreatment of p53 wild-type cells can exacerbate this TPEN-induced early commitment to apoptosis. This suggests that low free [Zn 2ϩ ] i can permit normally subthreshold levels of VP-16-induced DNA damage to trigger apoptosis. The p53 mutant cell line shows a highly muted apoptotic response to VP-16-induced DNA damage. However, the difference in the TPEN apoptotic response between the two cell lines is far less pronounced. TPEN exposure results in up to 40% of SU-DHL-4 cells progressing to limited nuclear fragmentation, with kinetics very similar to those for DoHH2 cells. Thus it appears that following a short or sustained reduction in free [Zn 2ϩ ] i , the p53 mutant cell line can also engage elements of the apoptotic pathway, reenforcing the concept that low free [Zn In this model, [Zn 2ϩ ] i homeostasis is an integral part of the DNA fragmentation response. Accordingly, enforcing increased levels of free intracellular Zn 2ϩ might be expected to inhibit cell death (10) . The presence of Zn 2ϩ in culture medium can interfere with DNA damage-associated apoptosis in UVB-irradiated HaCaT keratinocytes (2) and cisplatin-treated HeLa cells (27) . On the other hand, concentrations of extracellular Zn 2ϩ (500-1,000 M) have been used to block, at least short-term, glucocorticoid-induced apoptosis in thymocytes, whereas lower or more physiological concentrations of Zn 2ϩ (80-200 M) appear to be able to induce cell death (18) . The balance between the basal level of free intracellular Zn 2ϩ in a cell, the extent of stressinduced release of Zn 2ϩ , and the early Zn 2ϩ -consumption requirements of a cell for the pursuit of apoptosis would potentially affect the efficiency with which apoptosis is inhibited by extracellular Zn 2ϩ . The setting of the balance for free [Zn 2ϩ ] i would also contribute to the cell cycle heterogeneity, intercell line variation, and the complex effects of chelating agents and extracellular Zn 2ϩ . It appears that cells may integrate Zn 2ϩ homeostasis with apoptosis at the level of caspase function, providing control over internucleosomal fragmentation and the cleavage of the DNase inhibitor ICAD. Zn 2ϩ depletion-induced apoptosis by TPEN is associated with activation of caspases-3, -8, and -9 and cleavage of target proteins (11) . Additionally, Zn 2ϩ addition partially inhibits caspase-3 activation, but not caspase-8 and -9 cleavage, in VP-16-treated HeLa cells (11) , suggesting that the impact of upstream DNA damageoriginating apoptotic signals may be affected by intracellular Zn 2ϩ availability at the level of caspase-3. In cells undergoing oxidative stress, limited caspase-3 activation can occur with a resumption of activation and progression to internucleosomal fragmentation upon mild Zn 2ϩ chelation (26) . Such observations suggest that in the presence of strong or persistent apoptotic signals, relatively small-scale changes in free [Zn 2ϩ ] i may play a critical role in the full engagement and active pursuance of apoptosis. Accordingly the induction of apoptosis by TPEN in both DoHH2 and SU-DHL-4 cells could result from activation of caspase-3 and serves to demonstrate the functional integrity of the downstream apoptotic cascade even in the p53 mutant cell line. We suggest that the observed collapse of the [Zn 2ϩ ] i transient in high-dose VP-16-treated DoHH2 cells results in a partial activation of caspase-3, permitting the rapid and extensive triggering of apoptosis through DNA damage signaling. The early enhancement of VP-16-induced apoptosis by TPEN in the p53 wild-type cell line could arise from the reenforcement of upstream proapoptotic signals acting at a partially activated caspase-3.
The initial increase in [Zn 2ϩ ] i would provide resistance to apoptotic signals through caspase-3 partial inactivation while the cell attempts to initiate checkpoint activation. Our VP-16 cell cycle study indicates that both lymphoma cell lines show similar potential for cycle arrest, except that events in DoHH2 cells are truncated by the engagement of apoptosis. Other studies have shown that TPEN treatment of epithelial cells results in the early (1-2 h) activation of caspase-3 and in the rapid cleavage of p21 WAF1/CIP1 to a 15-kDa fragment before further degradation and the appearance of morphologic changes characteristic of apoptosis (9) . During the p53-mediated response to gamma radiation-induced DNA damage, p21 WAF1/CIP1 is rapidly induced but selectively cleaved, probably by a caspase-3-like activity (19) . Cleavage abrogates interaction with proliferating cell nuclear antigen (PCNA) potentially interfering with normal PCNA-dependent repair and checkpoint function. A Zn 2ϩ transient may provide an apoptosis-inhibiting period during which the cleavage of target cell cycle inhibitor proteins is blocked, permitting the progressive recruitment of cells into cell cycle arrest. Zn 2ϩ transients have been observed in cells undergoing differentiation in culture (35) , and previous work using Zinquin has suggested that apoptosis, arising spontaneously or following induction by DNA-damaging agents, can be accompanied by a release of Zn 2ϩ from intracellular stores or MTs (50) . In assessing the reactive changes in shifts in free [Zn 2ϩ ] i induced by VP-16, it is clear that they are highly drug dose dependent. This reflects the sharp transition between the effects of low doses in permitting progression to G 2 /M arrest and the effects of higher doses (Ͼ0.5 M) in trapping cells in S phase and inducing an earlier commitment to apoptosis (41) as threshold levels of damage are surpassed (32) . The ability to observe free [Zn 2ϩ ] i transients is severely restricted by the rapidity with which permissive cells commit to apoptosis and thereupon reduce available intracellular Zn 2ϩ levels. We have observed that cells with compromised membrane integrity also show elevated Zinquin fluorescence. This potential artifact was specifically excluded from our measurements.
The origin of the increases in free [Zn 2ϩ ] i is assumed to be preexisting intracellular MT pools (4 -sequestering molecules such as MTs and exogenously supplied chelating agents on the two main competing responses of human cells to genomic stress that can affect population dynamics, namely, the resolution of cell cycle arrest vs. active progression to cell death. We suggest that heterogeneity in intracellular Zn 2ϩ levels within normal tissues and, indeed, tumor cell populations could act to limit their ability to collapse free intracellular Zn 2ϩ concentrations and efficiently pursue cell death responses to physiologically derived signals or those arising from imposed genomic stress.
The dynamic processes that lead to Zn 2ϩ transients and collapse are not clear, although the current study emphasizes the event heterogeneity and rapidity. If such events occur in parallel with the initiation of cycle arrest and the transduction of apoptotic signals, then their impact on the modulation of caspase activity or p53-driven processes will depend on when they occur. Studies involving enforced changes of Zn 2ϩ levels by chelation cannot reproduce or mimic the temporal linking of such Zn 2ϩ changes with those signals. Future studies should address the nature of Zn 2ϩ profiles in single cells containing additional reporters to provide the temporal linking to damage signaling events.
The concept that apoptosis is engaged as thresholds of DNA damage are surpassed has been discussed previously and describes an important strategy in mammals for coping with injury and tissue organization (32) . The implication of the current study is that free [Zn 2ϩ ] i transients imposed by physiological changes could determine the thresholds for engaging cell death pathways under biologically relevant levels of persistent genomic stress.
